| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.5M | — |
| Cost of Revenue | $3.5M | -4.3% |
| Gross Profit | $2.0M | — |
| R&D Expense | $697K | +38.3% |
| SG&A Expense | $4.0M | +5068.2% |
| Operating Income | -$4.2M | -2601.3% |
| Pre-tax Income | -$4.2M | -130.9% |
| Net Income | -$4.9M | -2234.4% |
| EPS (Basic) | -$0.09 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $1.0M | +63.0% |
| Inventory | $2.6M | +108.3% |
| Current Assets | $4.4M | — |
| Total Assets | $6.7M | — |
| Current Liabilities | $3.7M | +7297.6% |
| Total Liabilities | $5.0M | +3217.2% |
| Stockholders' Equity | -$23.4M | — |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.7M | -2344.6% |
| Capital Expenditures | $263K | +1361.1% |
| Investing Cash Flow | -$263K | -1361.1% |
| Financing Cash Flow | $2.9M | +2759.2% |
| Free Cash Flow | -$2.9M | -2205.4% |
| — |